With the addition of the newly executed Provider Participation Agreements,GMEDx has further and significantly increased its footprint in the healthcare delivery system of cardiac monitoring and provide more exposure to our future patient base and third-party payer populations.Obtaining additional access to Medicare reimbursements for covered services rendered to covered persons for all applicable programs associated under the PPA with PHS and ACS will translate to increased revenue opportunity for GMEDx,as these services are carried out based on individual patient requirements, the treatment modalities utilised and term and frequency of treatment.There is no immediate revenue impact from the PPAs,and the future revenue opportunity to GMEDx is subject to PHS’s and ACS’s individual patient requirements.
Amazing how posters get attacked quoting the companies own words.
Chief- You are a very logical and balanced poster.
Ann: Execution of US Provider Agreements, page-9
Add to My Watchlist
What is My Watchlist?